Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Julie Rubinstein. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Julie Rubinstein har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:ADPT / Adaptive Biotechnologies Corporation | President and COO | 377 802 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Julie Rubinstein. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ADPT / Adaptive Biotechnologies Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ADPT / Adaptive Biotechnologies Corporation. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ADPT / Adaptive Biotechnologies Corporation. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Julie Rubinstein som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 037 | 377 802 | −4,80 | 14,23 | −270 897 | 5 376 122 |
| 2026-04-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 707 | 396 839 | 3,85 | 8,46 | 124 421 | 3 357 258 |
| 2026-04-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 382 132 | −4,75 | 14,02 | −267 221 | 5 357 491 |
| 2026-04-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 401 192 | 3,81 | 8,46 | 124 548 | 3 394 084 |
| 2026-04-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 386 470 | −4,70 | 13,74 | −261 884 | 5 310 098 |
| 2026-04-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 405 530 | 3,77 | 8,46 | 124 548 | 3 430 784 |
| 2026-04-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 390 808 | −4,65 | 14,13 | −269 318 | 5 522 117 |
| 2026-04-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 409 868 | 3,73 | 8,46 | 124 548 | 3 467 483 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −30 941 | 395 146 | −7,26 | 14,66 | −453 595 | 5 792 840 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 426 087 | 2,87 | 12,14 | 144 235 | 5 172 696 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 414 206 | 3,69 | 8,46 | 124 548 | 3 504 183 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 399 484 | −4,55 | 14,55 | −277 323 | 5 812 492 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 418 544 | 3,65 | 8,46 | 124 548 | 3 540 882 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 403 822 | −4,51 | 14,57 | −277 704 | 5 883 687 |
| 2026-04-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 422 882 | 3,61 | 8,46 | 124 548 | 3 577 582 |
| 2026-04-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 408 160 | −4,46 | 14,18 | −270 271 | 5 787 709 |
| 2026-04-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 427 220 | 3,57 | 8,46 | 124 548 | 3 614 281 |
| 2026-04-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 412 498 | −4,42 | 14,61 | −278 467 | 6 026 596 |
| 2026-04-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 431 558 | 3,53 | 8,46 | 124 548 | 3 650 981 |
| 2026-04-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 416 836 | −4,37 | 14,56 | −277 514 | 6 069 132 |
| 2026-04-16 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 435 896 | 3,50 | 8,46 | 124 548 | 3 687 680 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 338 | 421 174 | −0,79 | 14,08 | −46 999 | 5 930 130 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −15 722 | 424 512 | −3,57 | 12,95 | −203 600 | 5 497 430 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 6 613 | 440 234 | 1,53 | 8,46 | 55 946 | 3 724 380 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 8 109 | 433 621 | 1,91 | 7,27 | 58 952 | 3 152 425 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −400 | 425 512 | −0,09 | 13,48 | −5 392 | 5 735 902 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −18 660 | 425 912 | −4,20 | 12,75 | −237 915 | 5 430 378 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 444 572 | 3,42 | 7,27 | 107 029 | 3 232 038 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 100 | 429 850 | −0,49 | 14,44 | −30 324 | 6 207 034 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −16 960 | 431 950 | −3,78 | 13,79 | −233 878 | 5 956 590 |
| 2026-04-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 448 910 | 3,39 | 7,27 | 107 029 | 3 263 576 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −100 | 434 188 | −0,02 | 15,48 | −1 548 | 6 721 230 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −30 841 | 434 288 | −6,63 | 14,83 | −457 372 | 6 440 491 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 465 129 | 2,62 | 12,14 | 144 235 | 5 646 666 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 453 248 | 3,36 | 7,27 | 107 029 | 3 295 113 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 438 526 | −4,17 | 13,56 | −258 454 | 5 946 413 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 457 586 | 3,32 | 7,27 | 107 029 | 3 326 650 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 442 864 | −4,13 | 14,33 | −273 130 | 6 346 241 |
| 2026-04-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 461 924 | 3,29 | 7,27 | 107 029 | 3 358 187 |
| 2026-04-02 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 447 202 | −4,09 | 14,60 | −278 276 | 6 529 149 |
| 2026-04-02 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 466 262 | 3,26 | 7,27 | 107 029 | 3 389 725 |
| 2026-04-02 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 451 540 | −4,05 | 14,45 | −275 417 | 6 524 753 |
| 2026-04-02 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 470 600 | 3,23 | 7,27 | 107 029 | 3 421 262 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 455 878 | −4,01 | 13,45 | −256 357 | 6 131 559 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 474 938 | 3,20 | 7,27 | 107 029 | 3 452 799 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 460 216 | −3,98 | 12,63 | −240 728 | 5 812 528 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 479 276 | 3,17 | 7,27 | 107 029 | 3 484 337 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −16 322 | 464 554 | −3,39 | 13,48 | −220 021 | 6 262 188 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 738 | 480 876 | −0,57 | 12,49 | −34 198 | 6 006 141 |
| 2026-03-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 483 614 | 3,14 | 7,27 | 107 029 | 3 515 874 |
| 2026-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 468 892 | −3,91 | 14,12 | −269 127 | 6 620 755 |
| 2026-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 487 952 | 3,11 | 7,27 | 107 029 | 3 547 411 |
| 2026-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 473 230 | −3,87 | 14,27 | −271 986 | 6 752 992 |
| 2026-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 492 290 | 3,08 | 7,27 | 107 029 | 3 578 948 |
| 2026-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 477 568 | −3,84 | 13,70 | −261 122 | 6 542 682 |
| 2026-03-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 496 628 | 3,05 | 7,27 | 107 029 | 3 610 486 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 481 906 | −3,80 | 13,83 | −263 600 | 6 664 760 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 500 966 | 3,03 | 7,27 | 107 029 | 3 642 023 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 486 244 | −3,77 | 13,37 | −254 832 | 6 501 082 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 10 783 | 505 304 | 2,18 | 7,27 | 78 392 | 3 673 560 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 3 939 | 494 521 | 0,80 | 6,55 | 25 800 | 3 239 113 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 490 582 | −3,74 | 13,18 | −251 211 | 6 465 871 |
| 2026-03-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 509 642 | 2,97 | 6,55 | 96 429 | 3 338 155 |
| 2026-03-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 494 920 | −3,71 | 13,18 | −251 211 | 6 523 046 |
| 2026-03-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 513 980 | 2,95 | 6,55 | 96 429 | 3 366 569 |
| 2026-03-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 499 258 | −3,68 | 13,40 | −255 404 | 6 690 057 |
| 2026-03-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 518 318 | 2,92 | 6,55 | 96 429 | 3 394 983 |
| 2026-03-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 503 596 | −3,65 | 13,41 | −255 595 | 6 753 222 |
| 2026-03-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 522 656 | 2,90 | 6,55 | 96 429 | 3 423 397 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 507 934 | −3,62 | 12,96 | −247 018 | 6 582 825 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 526 994 | 2,87 | 6,55 | 96 429 | 3 451 811 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 400 | 512 272 | −1,04 | 13,43 | −72 522 | 6 879 813 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −13 660 | 517 672 | −2,57 | 12,63 | −172 526 | 6 538 197 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 531 332 | 2,85 | 6,55 | 96 429 | 3 480 225 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 060 | 516 610 | −3,56 | 14,08 | −268 365 | 7 273 869 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 535 670 | 2,83 | 6,55 | 96 429 | 3 508 638 |
| 2026-03-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −122 523 | 520 948 | −19,04 | 13,17 | −1 613 628 | 6 860 885 | |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −19 460 | 643 471 | −2,94 | 14,68 | −285 673 | 9 446 154 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 400 | 662 931 | 0,06 | 12,14 | 4 856 | 8 047 982 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 662 531 | 2,27 | 6,55 | 96 429 | 4 339 578 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −30 941 | 647 809 | −4,56 | 14,79 | −457 617 | 9 581 095 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 678 750 | 1,78 | 12,14 | 144 235 | 8 240 025 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 666 869 | 2,26 | 6,55 | 96 429 | 4 367 992 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −30 941 | 652 147 | −4,53 | 15,14 | −468 447 | 9 873 506 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 683 088 | 1,77 | 12,14 | 144 235 | 8 292 688 |
| 2026-03-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 671 207 | 2,24 | 6,55 | 96 429 | 4 396 406 |
| 2026-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 81 250 | 656 485 | 14,12 | ||||
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −30 941 | 575 235 | −5,10 | 16,00 | −495 056 | 9 203 760 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 606 176 | 2,00 | 12,14 | 144 235 | 7 358 977 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 594 295 | 2,54 | 6,55 | 96 429 | 3 892 632 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −30 941 | 579 573 | −5,07 | 16,60 | −513 621 | 9 620 912 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 610 514 | 1,98 | 12,14 | 144 235 | 7 411 640 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 598 633 | 2,52 | 6,55 | 96 429 | 3 921 046 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 518 | 583 911 | −1,10 | 16,33 | −106 439 | 9 535 267 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −24 423 | 590 429 | −3,97 | 15,49 | −378 312 | 9 145 745 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 11 881 | 614 852 | 1,97 | 12,14 | 144 235 | 7 464 303 |
| 2026-03-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 722 | 602 971 | 2,50 | 6,55 | 96 429 | 3 949 460 |
| 2025-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −19 461 | 588 249 | −3,20 | 6,99 | −136 032 | 4 111 861 | |
| 2025-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −40 044 | 607 710 | −6,18 | 6,98 | −279 507 | 4 241 816 | |
| 2025-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 175 000 | 647 754 | 37,02 | ||||
| 2024-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −13 490 | 472 754 | −2,77 | 3,56 | −48 024 | 1 683 004 | |
| 2024-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −25 580 | 486 244 | −5,00 | 3,43 | −87 739 | 1 667 817 | |
| 2024-03-06 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 175 000 | 511 824 | 51,96 | ||||
| 2023-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −22 668 | 336 824 | −6,31 | 8,57 | −194 265 | 2 886 582 | |
| 2023-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 132 979 | 359 492 | 58,71 | ||||
| 2022-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −4 613 | 226 513 | −2,00 | 12,01 | −55 402 | 2 720 421 | |
| 2022-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | 463 344 | 463 344 | |||||
| 2022-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 185 338 | 231 126 | 404,77 | ||||
| 2021-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | 114 469 | 114 469 | |||||
| 2021-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | 45 788 | 45 788 | |||||
| 2021-03-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 225 325 | −6,24 | |||
| 2021-03-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −845 | 0 | −100,00 | 58,99 | −49 847 | |
| 2021-03-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 471 | 845 | −91,81 | 58,64 | −555 379 | 49 551 |
| 2021-03-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 684 | 10 316 | −31,23 | 57,54 | −269 517 | 593 583 |
| 2021-03-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-03-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 240 325 | −5,87 | |||
| 2021-03-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 56,23 | −843 450 | |
| 2021-03-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −14 675 | 255 325 | −5,44 | |||
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −599 | 0 | −100,00 | 57,33 | −34 341 | |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −14 076 | 599 | −95,92 | 56,13 | −790 086 | 33 622 |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 675 | 14 675 | 6,55 | 96 121 | 96 121 | |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 270 000 | −5,26 | |||
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 258 | 0 | −100,00 | 59,33 | −193 297 | |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 374 | 3 258 | −50,87 | 58,74 | −198 189 | 191 375 |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 134 | 6 632 | −38,40 | 57,12 | −236 134 | 378 820 |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 234 | 10 766 | −28,23 | 56,45 | −239 009 | 607 741 |
| 2021-02-26 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 255 000 | −5,56 | |||
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 039 | 0 | −100,00 | 56,04 | −394 466 | |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 461 | 7 039 | −38,79 | 55,54 | −247 764 | 390 946 |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 500 | 11 500 | −23,33 | 54,16 | −189 560 | 622 840 |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 270 000 | −5,26 | |||
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −656 | 0 | −100,00 | 62,20 | −40 803 | |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −400 | 656 | −37,88 | 61,01 | −24 404 | 40 023 |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 100 | 1 056 | −79,52 | 60,21 | −246 861 | 63 582 |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 844 | 5 156 | −65,63 | 59,28 | −583 552 | 305 648 |
| 2021-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 285 000 | −5,00 | |||
| 2021-02-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 793 | 0 | −100,00 | 63,03 | −239 073 | |
| 2021-02-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 708 | 3 793 | −67,02 | 62,30 | −480 208 | 236 304 |
| 2021-02-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 499 | 11 501 | −23,33 | 61,47 | −215 084 | 706 966 |
| 2021-02-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 300 000 | −4,76 | |||
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 108 | 0 | −100,00 | 61,20 | −557 410 | |
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 892 | 9 108 | −39,28 | 60,49 | −356 407 | 550 943 |
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 315 000 | −4,55 | |||
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 799 | 0 | −100,00 | 62,28 | −610 282 | |
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 201 | 9 799 | −34,67 | 61,63 | −320 538 | 603 912 |
| 2021-02-19 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 330 000 | −4,35 | |||
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −13 301 | 0 | −100,00 | 65,31 | −868 688 | |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 699 | 13 301 | −11,33 | 64,78 | −110 061 | 861 639 |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 345 000 | −4,17 | |||
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 67,00 | −20 100 | |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 621 | 300 | −96,98 | 66,38 | −638 642 | 19 914 |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 130 | 9 921 | −23,98 | 65,55 | −205 172 | 650 322 |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 949 | 13 050 | −12,99 | 64,53 | −125 769 | 842 116 |
| 2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 360 000 | −4,00 | |||
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 271 | 0 | −100,00 | 63,67 | −271 935 | |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −10 729 | 4 271 | −71,53 | 63,12 | −677 214 | 269 586 |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 375 000 | −3,85 | |||
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −618 | 0 | −100,00 | 64,76 | −40 022 | |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 798 | 618 | −86,01 | 64,09 | −243 414 | 39 608 |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 814 | 4 416 | −46,34 | 63,00 | −240 282 | 278 208 |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 770 | 8 230 | −45,13 | 62,14 | −420 688 | 511 412 |
| 2021-02-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,55 | 98 250 | 98 250 | |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 390 000 | −2,50 | |||
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 389 | 0 | −100,00 | 63,02 | −465 655 | |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 611 | 7 389 | −50,74 | 61,81 | −470 436 | 456 714 |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 6,32 | 31 600 | 94 800 |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 6,55 | 65 500 | 65 500 | |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 5 000 | −75,00 | |||
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 344 | 0 | −100,00 | 62,43 | −271 196 | |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −10 656 | 4 344 | −71,04 | 61,96 | −660 246 | 269 154 |
| 2021-02-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-02-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 20 000 | −42,86 | |||
| 2021-02-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 850 | 0 | −100,00 | 60,12 | −592 182 | |
| 2021-02-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 150 | 9 850 | −34,33 | 59,64 | −307 146 | 587 454 |
| 2021-02-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 35 000 | −30,00 | |||
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 695 | 0 | −100,00 | 59,25 | −396 679 | |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 305 | 6 695 | −55,37 | 58,77 | −488 085 | 393 465 |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 50 000 | −23,08 | |||
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −910 | 0 | −100,00 | 60,82 | −55 346 | |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 435 | 910 | −85,66 | 60,16 | −326 970 | 54 746 |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 655 | 6 345 | −57,70 | 59,39 | −514 020 | 376 830 |
| 2021-02-05 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 65 000 | −18,75 | |||
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 010 | 0 | −100,00 | 59,99 | −120 580 | |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 280 | 2 010 | −72,43 | 59,20 | −312 576 | 118 992 |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 710 | 7 290 | −51,40 | 58,58 | −451 652 | 427 048 |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 80 000 | −15,79 | |||
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 055 | 0 | −100,00 | 56,01 | −227 121 | |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −10 945 | 4 055 | −72,97 | 55,36 | −605 915 | 224 485 |
| 2021-02-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-02-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 95 000 | −13,64 | |||
| 2021-02-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 796 | 0 | −100,00 | 57,74 | −103 701 | |
| 2021-02-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 910 | 1 796 | −73,22 | 56,60 | −277 906 | 101 654 |
| 2021-02-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 294 | 6 706 | −55,29 | 55,77 | −462 556 | 373 994 |
| 2021-02-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 110 000 | −12,00 | |||
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 147 | 0 | −100,00 | 56,68 | −121 692 | |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 420 | 2 147 | −81,44 | 55,96 | −527 143 | 120 146 |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 433 | 10 567 | −24,52 | 54,96 | −188 678 | 580 762 |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 125 000 | −10,71 | |||
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 700 | 0 | −100,00 | 59,99 | −101 983 | |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 913 | 1 700 | −80,26 | 59,37 | −410 425 | 100 929 |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 387 | 8 613 | −42,58 | 58,19 | −371 660 | 501 190 |
| 2021-01-29 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 140 000 | −9,68 | |||
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −600 | 0 | −100,00 | 65,90 | −39 540 | |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 470 | 600 | −85,26 | 65,28 | −226 522 | 39 168 |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −10 930 | 4 070 | −72,87 | 64,32 | −703 018 | 261 782 |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 155 000 | −8,82 | |||
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 67,79 | −33 895 | |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 816 | 500 | −94,63 | 67,05 | −591 113 | 33 525 |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 813 | 9 316 | −16,29 | 65,89 | −119 459 | 613 831 |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 871 | 11 129 | −25,81 | 65,09 | −251 963 | 724 387 |
| 2021-01-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 170 000 | −8,11 | |||
| 2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 476 | 0 | −100,00 | 67,19 | −636 692 | |
| 2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 524 | 9 476 | −36,83 | 66,23 | −365 855 | 627 595 |
| 2021-01-25 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 185 000 | −7,50 | |||
| 2021-01-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −45 | 0 | −100,00 | 67,63 | −3 043 | |
| 2021-01-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 511 | 45 | −99,47 | 66,87 | −569 131 | 3 009 |
| 2021-01-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 444 | 8 556 | −42,96 | 66,15 | −426 271 | 565 979 |
| 2021-01-22 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 200 000 | −6,98 | |||
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 370 | 0 | −100,00 | 68,34 | −435 326 | |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 264 | 6 370 | −40,10 | 67,58 | −288 161 | 430 485 |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 366 | 10 634 | −29,11 | 66,49 | −290 295 | 707 055 |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 215 000 | −6,52 | |||
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 71,23 | −14 246 | |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 822 | 200 | −96,02 | 70,51 | −339 999 | 14 102 |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 415 | 5 022 | −59,62 | 69,54 | −515 639 | 349 230 |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 563 | 12 437 | −17,09 | 68,72 | −176 129 | 854 671 |
| 2021-01-21 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 230 000 | −6,12 | |||
| 2021-01-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −1 491 | 0 | −100,00 | 67,19 | −100 180 | ||
| 2021-01-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 802 | 1 491 | −85,51 | 66,47 | −585 069 | 99 107 |
| 2021-01-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 707 | 10 293 | −31,38 | 65,47 | −308 167 | 673 883 |
| 2021-01-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 245 000 | −5,77 | |||
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 461 | 0 | −100,00 | 66,35 | −163 287 | |
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −12 539 | 2 461 | −83,59 | 65,48 | −821 054 | 161 146 |
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 260 000 | −5,45 | |||
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 885 | 0 | −100,00 | 63,72 | −438 712 | |
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 115 | 6 885 | −54,10 | 62,79 | −509 541 | 432 309 |
| 2021-01-15 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 275 000 | −5,17 | |||
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 128 | 0 | −100,00 | 63,10 | −323 577 | |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 872 | 5 128 | −65,81 | 62,47 | −616 704 | 320 346 |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 290 000 | −4,92 | |||
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −9 756 | 0 | −100,00 | 61,74 | −602 335 | |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 544 | 9 756 | −20,68 | 60,68 | −154 370 | 591 994 |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 700 | 12 300 | −18,00 | 59,62 | −160 974 | 733 326 |
| 2021-01-13 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 305 000 | −4,69 | |||
| 2021-01-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 944 | 0 | −100,00 | 61,35 | −303 314 | |
| 2021-01-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | 6 186 | 4 944 | −498,07 | 60,44 | 373 882 | 298 815 |
| 2021-01-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 213 | 11 130 | −16,59 | 59,70 | −132 116 | 664 461 |
| 2021-01-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 657 | 13 343 | −11,05 | 58,82 | −97 465 | 784 835 |
| 2021-01-11 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 320 000 | −4,48 | |||
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | −15 000 | 0 | −100,00 | 57,30 | −859 500 | ||
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 335 000 | −4,29 | |||
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −808 | 0 | −100,00 | 55,45 | −44 804 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −14 192 | 808 | −94,61 | 54,86 | −778 573 | 44 327 |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 350 000 | −4,11 | |||
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −363 | 0 | −100,00 | 56,56 | −20 531 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −14 637 | 363 | −97,58 | 55,98 | −819 379 | 20 321 |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 365 000 | −3,95 | |||
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −709 | 0 | −100,00 | 59,40 | −42 115 | |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −4 751 | 709 | −87,01 | 58,09 | −275 986 | 41 186 |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 169 | 5 460 | −36,72 | 57,52 | −182 281 | 314 059 |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 371 | 8 629 | −42,47 | 56,05 | −357 095 | 483 655 |
| 2021-01-07 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 380 000 | −3,80 | |||
| 2020-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −638 | 0 | −100,00 | 59,27 | −37 814 | |
| 2020-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 386 | 638 | −90,92 | 58,25 | −371 984 | 37 164 |
| 2020-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 976 | 7 024 | −53,17 | 57,56 | −459 099 | 404 301 |
| 2020-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 395 000 | −3,66 | |||
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 700 | 0 | −100,00 | 60,12 | −102 204 | |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −13 300 | 1 700 | −88,67 | 59,55 | −792 015 | 101 235 |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 410 000 | −3,53 | |||
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 853 | 0 | −100,00 | 61,32 | −113 626 | |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 922 | 1 853 | −78,88 | 60,72 | −420 304 | 112 514 |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −6 225 | 8 775 | −41,50 | 59,48 | −370 263 | 521 937 |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 425 000 | −3,41 | |||
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 63,95 | −12 790 | |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −2 258 | 200 | −91,86 | 63,33 | −142 999 | 12 666 |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 735 | 2 458 | −60,31 | 62,04 | −231 719 | 152 494 |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 807 | 6 193 | −58,71 | 60,89 | −536 258 | 377 092 |
| 2020-12-30 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 440 000 | −3,30 | |||
| 2020-12-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −378 | 0 | −100,00 | 65,39 | −24 717 | |
| 2020-12-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 741 | 378 | −90,82 | 64,29 | −240 509 | 24 302 |
| 2020-12-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 394 | 4 119 | −64,22 | 63,71 | −471 072 | 262 421 |
| 2020-12-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 487 | 11 513 | −23,25 | 62,15 | −216 717 | 715 533 |
| 2020-12-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 455 000 | −3,19 | |||
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 029 | 0 | −100,00 | 65,41 | −67 307 | |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 506 | 1 029 | −84,25 | 64,59 | −355 633 | 66 463 |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −8 465 | 6 535 | −56,43 | 63,90 | −540 914 | 417 586 |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 470 000 | −3,09 | |||
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −1 900 | 0 | −100,00 | 64,36 | −122 284 | |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −13 100 | 1 900 | −87,33 | 63,62 | −833 422 | 120 878 |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 485 000 | −3,00 | |||
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 323 | 0 | −100,00 | 59,72 | −437 330 | |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −7 677 | 7 323 | −51,18 | 59,15 | −454 095 | 433 155 |
| 2020-12-23 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 000 | 15 000 | 6,32 | 94 800 | 94 800 | |
| 2020-10-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −14 725 | 0 | −100,00 | |||
| 2020-10-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −14 725 | 0 | −100,00 | 49,00 | −721 525 | |
| 2020-10-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 14 725 | 14 725 | 0,84 | 12 369 | 12 369 | |
| 2020-10-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −80 000 | 14 725 | −84,46 | |||
| 2020-10-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −80 000 | 0 | −100,00 | 49,00 | −3 920 000 | |
| 2020-10-01 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 80 000 | 80 000 | 0,84 | 67 200 | 67 200 | |
| 2020-07-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −15 275 | 94 725 | −13,89 | |||
| 2020-07-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −15 275 | 0 | −100,00 | 49,00 | −748 475 | |
| 2020-07-10 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 15 275 | 15 275 | 0,84 | 12 831 | 12 831 | |
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −30 000 | 110 000 | −21,43 | |||
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 140 | 0 | −100,00 | 39,13 | −201 128 | |
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −24 860 | 5 140 | −82,87 | 38,20 | −949 652 | 196 348 |
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 30 000 | 30 000 | 0,84 | 25 200 | 25 200 | |
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −80 000 | 140 000 | −36,36 | |||
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −80 000 | 0 | −100,00 | 38,00 | −3 040 000 | |
| 2020-05-12 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 80 000 | 80 000 | 0,84 | 67 200 | 67 200 | |
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 220 000 | −2,22 | |||
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 33,55 | −167 750 | |
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 0,84 | 4 200 | 4 200 | |
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −80 000 | 225 000 | −26,23 | |||
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −12 200 | 0 | −100,00 | 34,01 | −414 922 | |
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −67 800 | 12 200 | −84,75 | 33,49 | −2 270 622 | 408 578 |
| 2020-02-24 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 80 000 | 80 000 | 0,84 | 67 200 | 67 200 | |
| 2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −55 000 | 305 000 | −15,28 | |||
| 2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 0 | −100,00 | |||
| 2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −80 000 | 0 | −100,00 | 33,00 | −2 640 000 | |
| 2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 55 000 | 80 000 | 220,00 | 0,84 | 46 200 | 67 200 |
| 2020-02-20 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 25 000 | 25 000 | 0,84 | 21 000 | 21 000 | |
| 2020-02-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | 200 000 | 200 000 | |||||
| 2020-01-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −40 000 | 25 000 | −61,54 | |||
| 2020-01-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −40 000 | 0 | −100,00 | 30,00 | −1 200 000 | |
| 2020-01-03 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 40 000 | 40 000 | 0,84 | 33 600 | 33 600 | |
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −55 000 | 0 | −100,00 | |||
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −3 500 | 0 | −100,00 | 29,12 | −101 920 | |
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −51 500 | 3 500 | −93,64 | 28,51 | −1 468 265 | 99 785 |
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 55 000 | 55 000 | 0,45 | 24 750 | 24 750 | |
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −45 000 | 55 000 | −45,00 | |||
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −35 000 | 0 | −100,00 | |||
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −80 000 | 0 | −100,00 | 29,28 | −2 342 400 | |
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 45 000 | 80 000 | 128,57 | 0,45 | 20 250 | 36 000 |
| 2019-12-31 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 35 000 | 35 000 | 0,45 | 15 750 | 15 750 | |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −35 000 | 35 000 | −50,00 | |||
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −45 000 | 0 | −100,00 | |||
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −80 000 | 0 | −100,00 | 29,37 | −2 349 600 | |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 35 000 | 80 000 | 77,78 | 0,45 | 15 750 | 36 000 |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 45 000 | 45 000 | 0,33 | 14 850 | 14 850 | |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −55 000 | 45 000 | −55,00 | |||
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 0 | −100,00 | |||
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 30,61 | −15 305 | |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
S - Sale | X | −79 500 | 500 | −99,38 | 30,09 | −2 392 155 | 15 045 |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 55 000 | 80 000 | 220,00 | 0,33 | 18 150 | 26 400 |
| 2019-12-27 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
M - Exercise | X | 25 000 | 25 000 | 0,33 | 8 250 | 8 250 |
